Prosight Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50,154
Closed -$2.84M 28
2022
Q1
$2.84M Sell
50,154
-103,435
-67% -$5.4M 1.83% 17
2021
Q4
$7.97M Buy
153,589
+113,809
+286% +$5.87M 4.77% 6
2021
Q3
$2.38M Sell
39,780
-70,836
-64% -$4.46M 1.31% 28
2021
Q2
$6.87M Sell
110,616
-15,084
-12% -$1.01M 4.29% 6
2021
Q1
$8.19M Sell
125,700
-17,975
-13% -$1.17M 6.71% 3
2020
Q4
$9.45M Buy
143,675
+8,018
+6% +$472K 4.37% 8
2020
Q3
$7.01M Buy
135,657
+94,302
+228% +$4.84M 3.34% 11
2020
Q2
$2.04M Sell
41,355
-17,598
-30% -$950K 0.87% 31
2020
Q1
$3M Buy
+58,953
New +$3.4M 1.4% 24

Other funds holding EHC

Prosight Management's EHC Position: Q2 2022 in Review

Prosight Management sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 50,154 shares — an estimated $2.84M sold.

Prosight Management first reported a position in EHC in Q1 2020 and held it in 9 quarters. The position peaked at $9.45M in Q4 2020. 394 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

  • Prosight Management reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
  • Prosight Management sold 50,154 Encompass Health shares in Q2 2022, an estimated $2.84M.
  • Prosight Management first reported a position in Encompass Health in Q1 2020 and held it in 9 quarters.
  • Prosight Management's Encompass Health position peaked at $9.45M in Q4 2020.
  • 394 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Prosight Management's 13F filing for Q2 2022, filed 12 Aug 2022.